Single-centre vs. population-based outcome data of extremely preterm infants at the limits of viability

Patrizia Kutz1, Sandra Horsch, Lisa Kühn

  • 1Department of Neonatology and Paediatric Intensive Care, Vest Children's Hospital, University Witten-Herdecke, Datteln, Germany.

Insights

Improved survival and reduced disability were seen in extremely preterm infants born later. However, survival without disability at 23-24 weeks gestational age did not significantly improve.

Area of Science:

  • Neonatalogy
  • Perinatology
  • Pediatric Outcomes Research

Background:

  • The EPICure study (2000) reported disappointing outcomes for extremely preterm infants.
  • There is a need to assess contemporary outcomes for infants born at the threshold of viability.

Purpose of the Study:

  • To compare the outcomes of infants born between 22 0/7 and 25 6/7 weeks of gestational age (GA) in a single tertiary center (2000-2004) with the historical EPICure cohort.
  • To evaluate improvements in survival and neurodevelopmental outcomes.

Main Methods:

  • Utilized EPICure study's definitions and tools, including Bayley Scales of Infant Development at 30 months corrected age.
  • Retrospective comparison of a single-center cohort with the population-based EPICure cohort.

Main Results:

  • Infants born <26 weeks GA in the later cohort had higher intensive care admission rates (82% vs 68%) and significantly improved survival to discharge (57% vs 26%).
  • Survival without severe disability (41% vs 20%) and overall disability (22% vs 13%) was significantly higher in the later cohort.
  • However, for infants at the border of viability (23-24 weeks GA), survival without overall disability showed no significant improvement (13% vs 9%).

Conclusions:

  • A single-center cohort of extremely preterm infants born 5-8 years after the EPICure study demonstrated improved survival and reduced disability rates.
  • Despite overall improvements, enhanced survival without disability was not observed in the most vulnerable infants born at 23-24 weeks GA.
Abstract

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...